The Prognostic Impact of Cytogenetic Scores in Patients with Higher-Risk Myelodysplastic Syndrome Treated with Venetoclax and Azacitidine in a Phase 1 Study

被引：0

作者：

Garcia, Jacqueline S. ^{[1
]}

Wei, Andrew H. ^{[2
,3
]}

Borate, Uma ^{[4
]}

Fong, Chun Yew ^{[5
]}

Baer, Maria R. ^{[6
]}

Nolte, Florian ^{[7
]}

Peterlin, Pierre ^{[8
]}

Jurcic, Joseph ^{[9
]}

Jacoby, Meagan ^{[10
,11
]}

Hong, Wen-Jen ^{[12
]}

Platzbecker, Uwe ^{[13
]}

Odenike, Olatoyosi ^{[14
,15
]}

Cunningham, Ilona ^{[16
]}

Zhou, Ying ^{[17
]}

Dunbar, Martin ^{[17
]}

Harb, Jason G. ^{[17
]}

Popovic, Relja ^{[17
]}

Tanwani, Poonam ^{[17
]}

Gopalakrishnan, Sathej ^{[18
]}

Wolff, Johannes ^{[17
]}

Garcia-Manero, Guillermo ^{[19
]}

机构：

[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[2] Alfred Hosp, Dept Haematol, Melbourne, Vic, Australia

[3] Monash Univ, Melbourne, Vic, Australia

[4] Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol & Med Oncol, Portland, OR 97201 USA

[5] Austin Hlth, Olivia Newton John Canc Res Inst, Melbourne, Vic, Australia

[6] Univ Maryland, Sch Med, Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA

[7] Charite, Dept Hematol & Oncol, Campus Benjamin Franklin, Berlin, Germany

[8] Nantes Univ Hosp, Hematol Dept, Nantes, France

[9] Columbia Univ, Med Ctr, Myelodysplast Syndromes Ctr, New York, NY USA

[10] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO 63110 USA

[11] Washington Univ, Sch Med, St Louis, MO USA

[12] Genentech Inc, San Francisco, CA 94080 USA

[13] Univ Hosp Leipzig, Med Clin & Policlin 1, Hematol & Cellular Therapy, Leipzig, Germany

[14] Univ Chicago Med, Chicago, IL USA

[15] Comprehens Canc Ctr, Chicago, IL USA

[16] Univ Sydney, Concord Clin Sch, Sydney, NSW, Australia

[17] AbbVie Inc, N Chicago, IL USA

[18] AbbVie Deutschland GmbH & Co KG, Wiesbaden, Germany

[19] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2020年 / 20卷

关键词：

BCL-2; inhibitor; combination therapy; higher-risk MDS; efficacy; MDS; myelodysplastic syndromes;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MDS-141

引用

页码：S315 / S316

页数：2

共 50 条

[1] Predicting outcome in higher-risk myelodysplastic syndrome patients treated with azacitidine
Bouchla, Anthi
Thomopoulos, Thomas P.
Papageorgiou, Sotirios G.
Apostolopoulou, Christina
Loucari, Constantinos
Mpazani, Efthimia
Pappa, Vasiliki
EPIGENOMICS, 2021, 13 (14) : 1129 - 1143
[2] WT1 evaluation in higher-risk myelodysplastic syndrome patients treated with azacitidine
Falconi, Giulia
Fabiani, Emiliano
Ottone, Tiziana
Piciocchi, Alfonso
Lavorgna, Serena
Criscuolo, Marianna
Fianchi, Luana
Gurnari, Carmelo
Postorino, Massimiliano
Picardi, Alessandra
Palmieri, Raffaele
Lo-Coco, Francesco
Voso, Maria Teresa
LEUKEMIA & LYMPHOMA, 2020, 61 (04) : 979 - 982
[3] Phase 1 study of azacitidine in combination with evorpacept for higher-risk myelodysplastic syndrome (MDS)
Garcia-Manero, Guillermo
Scott, Bart L.
Kishtagari, Ashwin
Sanikommu, Srinivasa R.
Al-Kali, Aref
Lee, Je-Hwan
Burgues, Juan M. Bergua
Diez-Campelo, Maria
Erba, Harry P.
Garcia-Hernandez, Carmen
Santillana, Guillermo Sanz
O'Connell, Casey
Jang, Jun-Ho
Shin, Dong-Yeop
Sayar, Hamid
Rao, Mayank
Schwartz, Richard S.
An, Grace
Jin, Feng
Forgie, Alison J.
Tsiatis, Athanasios C.
Altman, Jessica K.
CANCER RESEARCH, 2024, 84 (07)
[4] Phase II study of azacitidine with pembrolizumab in patients with intermediate-1 or higher-risk myelodysplastic syndrome
Chien, Kelly S.
Kim, Kunhwa
Nogueras-Gonzalez, Graciela M.
Borthakur, Gautam
Naqvi, Kiran
Daver, Naval G.
Montalban-Bravo, Guillermo
Cortes, Jorge E.
DiNardo, Courtney D.
Jabbour, Elias
Alvarado, Yesid
Andreeff, Michael
Bose, Prithviraj
Jain, Nitin
Kadia, Tapan M.
Huang, Xuelin
Sheppard, Kimberly B.
Klingner-Winton, Cheri
Pierce, Sherry A.
Dong, Xiao Qin
Soltysiak, Kelly A.
Kantarjian, Hagop M.
Garcia-Manero, Guillermo
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (03) : 378 - 387
[5] A Phase 1b Study Evaluating the Safety and Efficacy of Venetoclax in Combination with Azacitidine in Treatment-Naive Patients with Higher-Risk Myelodysplastic Syndrome
Wei, Andrew H.
Garcia, Jacqueline S.
Borate, Uma
Fong, Chun Yew
Baer, Maria R.
Nolte, Florian
Peterlin, Pierre
Jurcic, Joseph G.
Garcia-Manero, Guillermo
Hong, Wan-Jen
Platzbecker, Uwe
Odenike, Olatoyosi
Dunbar, Martin
Zhou, Ying
Harb, Jason
Tanwani, Poonam
Wolff, Johannes E.
Jacoby, Meagan
BLOOD, 2019, 134
[6] Azacitidine and Venetoclax Combination for Upfront Treatment of Higher-Risk Myelodysplastic Syndromes
Al Ali, Najla
Sallman, David
Chan, Onyee
Padron, Eric
Sweet, Kendra
Kuykendall, Andrew
Lancet, Jeffrey
Komrokji, Rami
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S341 - S341
[7] Phase 1b study of venetoclax in combination with azacitidine in patients with treatment-naive higher-risk myelodysplastic syndromes.
Fong, Chun Yew
Wei, Andrew H.
Frattini, Mark G.
Jacoby, Meagan
Borate, Uma
Gotze, Katharina S.
Garcia, Jacqueline Suen
Pollyea, Daniel Aaron
Holes, Leanne
Zhou, Ying
Fakouhi, Kaffa Mussumeh
Leverson, Joel
Harb, Jason G.
Agarwal, Suresh K.
Attarchi, Faraneh
Mabry, Mack H.
Hong, Wan-Jen
Jahn, Thomas Michael
Fenaux, Pierre
Garcia-Manero, Guillermo
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[8] Safety, Efficacy, and Patient-Reported Outcomes of Venetoclax in Combination With Azacitidine for the Treatment of Patients With Higher-Risk Myelodysplastic Syndrome: A Phase 1b Study
不详
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (01) : 14 - 16
[9] Safety, Efficacy, and Patient-Reported Outcomes of Venetoclax in Combination with Azacitidine for the Treatment of Patients with Higher-Risk Myelodysplastic Syndrome: A Phase 1b Study
Garcia, Jacqueline S.
Wei, Andrew H.
Borate, Uma
Fong, Chun Yew
Baer, Maria R.
Nolte, Florian
Jurcic, Joseph G.
Jacoby, Meagan A.
Hong, Wan-Jen
Platzbecker, Uwe
Odenike, Olatoyosi
Cunningham, Ilona
Zhou, Ying
Tong, Bo
Hogdal, Leah
Kamalakar, Rajesh
Hutti, Jessica E.
Kye, Steve
Garcia-Manero, Guillermo
BLOOD, 2020, 136
[10] PHASE 3 VERONA STUDY ASSESSING THE SAFETY AND EFFICACY OF VENETOCLAX WITH AZACITIDINE IN PATIENTS WITH NEWLY DIAGNOSED HIGHER-RISK MYELODYSPLASTIC SYNDROMES
Zeidan, A. M.
Garcia, J.
Fenaux, P.
Platzbecker, U.
Miyazaki, Y.
Xiao, Z.
Zhou, Y.
Naqvi, K.
Kye, S.
Manero, G. Garcia
LEUKEMIA RESEARCH, 2021, 108 : S47 - S47

← 1 2 3 4 5 →